Reduced glucocorticoid receptor α expression in mood disorder patients and first-degree relatives

被引:78
作者
Matsubara, T [1 ]
Funato, H [1 ]
Kobayashi, A [1 ]
Nobumoto, M [1 ]
Watanabe, Y [1 ]
机构
[1] Yamaguchi Univ, Sch Med, Dept Neurosci, Div Neuropsychiat, Ube, Yamaguchi 7558505, Japan
关键词
glucocorticoid receptor isoforms alpha; beta; mood disorder; first-degree relatives of mood disorders; HPA axis; trait-marker; DEX/CRH test;
D O I
10.1016/j.biopsych.2005.09.026
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Individuals with mood disorders exhibit altered function of the hypothalamic-pituitiary-adrenal (HPA) axis in response to stress. The glucocorticoid receptor (GR) plays an important role in the negative feedback regulation of The HPA axis. There are two protein isoforms of GR GR alpha and GR beta which have distinct biological activity, It has not been examined whether GR alpha messenger RNA (mMNA) and GR beta mRNA expressions are altered in peripheral blood cells of mood disorder patients. Methods: Using quantitative reverse transcription polymerase chain. reaction (RT-PCR), GR alpha mRNA and GRP mRNA were measured in peripheral blood cells of major depressive disorder patients (depressive n = 18; remissive n = 38), bipolar disorder patients (depressive n = 13, remissive n = 35), normal control subjects (n = 31), and first-degree relatives bipolar depressive (n = 17) and bipolar (n = 15) disorder patients. Results: Reduced expression of GR alpha mRNA was shown in both bipolar and major depressive disorderpatients in a current depressive state as well as in remission. First-degree relatives of bipolar disorderpatients also showed GR alpha mRNA reduction, Altered GR beta mRNA expression was not found in mood disorder patients. Conclusions: Our results suggest that reduced GR alpha mRNA expression might be trait-dependent and associated with the pathophysiology of mood disorders.
引用
收藏
页码:689 / 695
页数:7
相关论文
共 61 条
[1]   Cytokines, stress and depressive illness: brain-immune interactions [J].
Anisman, H ;
Merali, Z .
ANNALS OF MEDICINE, 2003, 35 (01) :2-11
[2]   The role of corticotropin-releasing factor in depression and anxiety disorders [J].
Arborelius, L ;
Owens, MJ ;
Plotsky, PM ;
Nemeroff, CB .
JOURNAL OF ENDOCRINOLOGY, 1999, 160 (01) :1-12
[3]   GLUCOCORTICOID RECEPTOR-BETA, A POTENTIAL ENDOGENOUS INHIBITOR OF GLUCOCORTICOID ACTION IN HUMANS [J].
BAMBERGER, CM ;
BAMBERGER, AM ;
DECASTRO, M ;
CHROUSOS, GP .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (06) :2435-2441
[4]   DO ANTIDEPRESSANTS STABILIZE MOOD THROUGH ACTIONS ON THE HYPOTHALAMIC-PITUITARY-ADRENOCORTICAL SYSTEM [J].
BARDEN, N ;
REUL, JMHM ;
HOLSBOER, F .
TRENDS IN NEUROSCIENCES, 1995, 18 (01) :6-11
[5]   Characterization and functional significance of glucocorticoid receptors in patients with major depression: modulation by antidepressant treatment [J].
Calfa, G ;
Kademian, S ;
Ceschin, D ;
Vega, G ;
Rabinovich, GA ;
Volosin, M .
PSYCHONEUROENDOCRINOLOGY, 2003, 28 (05) :687-701
[6]  
Carlson CE, 1999, FEW BODY SY, V11, P10
[7]  
de Kloet E Ronald, 2003, Endocr Regul, V37, P51
[8]   Natural variants of the β isoform of the human glucocorticoid receptor do not alter sensitivity to glucocorticoids [J].
de Lange, P ;
Koper, JW ;
Brinkmann, AO ;
de Jong, FH ;
Lamberts, SWJ .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1999, 153 (1-2) :163-168
[9]   Very low levels of the glucocorticoid receptor β isoform in the human hippocampus as shown by Taqman RT-PCR and immunocytochemistry [J].
DeRijk, RH ;
Schaaf, M ;
Stam, FJ ;
de Jong, IEM ;
Swaab, DF ;
Ravid, R ;
Vreugdenhil, E ;
Cidlowski, JA ;
de Kloet, ER ;
Lucassen, PJ .
MOLECULAR BRAIN RESEARCH, 2003, 116 (1-2) :17-26
[10]  
GORMLEY GJ, 1985, AM J PSYCHIAT, V142, P1278